先健科技(01302.HK)主动脉覆膜支架系统获正式注册批准

阿斯达克财经
13 Feb

先健科技(01302.HK) 公布,由中国医学科学院阜外医院舒畅教授领衔与集团共同研发的主动脉覆膜支架系统获中国国家药品监督管理局正式注册批准。该产品为国家药品监督管理局批准的首款明确适用于烟囱技术的主动脉覆膜支架系统,为累及主动脉弓部病变的患者提供一种操作简便、安全有效、解剖适应广泛的治疗新选择。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-12 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10